Ownership of SNOMED CT® transferred to new international organisation

The newly-formed International Health Terminology Standards Development Organisation (IHTSDO®, also known as SNOMED SDO®) has acquired the intellectual property rights of SNOMED Clinical Terms (SNOMED CT®) and its antecedents from the College of American Pathologists (CAP) for $7.8 million, marking a milestone in the international standardization of health data.

The new international organization is assuming responsibility for the ongoing maintenance, development, quality assurance, and distribution of SNOMED CT®. The CAP will continue to support SDO operations under an initial 3-year contract and will continue to provide SNOMED-related products and services as a licensee of the terminology.

"We are delighted with the initial success of this truly international undertaking," said Professor Martin Severs, IHTSDO® Management Board chair. "Making SNOMED CT available this way is an example of how global health cooperation can benefit health systems, services, and products around the world."

"As the international adoption and use of SNOMED CT® has grown, it has become apparent that an international governance structure that is open to the entire global healthcare community would be to everyone's benefit," said Thomas Sodeman, MD, FCAP, president of the College of American Pathologists. "The College is proud to have assisted in this important milestone."

When implemented in software applications, SNOMED CT® can be used to represent clinically relevant information consistently worldwide as an integral part of producing standardized electronic health records. With a history dating back to 1965, SNOMED CT® (Systematized Nomenclature of Medicine Clinical Terms) is considered to be the most comprehensive, multilingual clinical healthcare terminology in the world.

SNOMED CT® was formed in 1999 by the convergence of SNOMED Reference Terminology (SNOMED RT®) and the United Kingdom's Clinical Terms Version 3 (formerly known as the Read Codes). Use of SNOMED CT® can support more effective and efficient health care and prevention within individual countries while also supporting enhanced international public health and research activities.

About the IHTSDO®
The IHTSDO® is registered as a not-for-profit association within Denmark. Its Charter Members are organizations representing Australia, Canada, Denmark, Lithuania, The Netherlands, New Zealand, Sweden, the United Kingdom, and the United States. Membership is open to all countries, and there is a provision for sponsored use in developing countries. The IHTSDO® will establish formal harmonization activities with other organizations, including the World Health Organization (WHO), to promote effective interoperability between SNOMED CT® and other health data standards. A description of IHTSDO®'s principles and objectives, open and participatory governance process, and uniform licensing terms is at http://www.ihtsdo.org.

About the College of American Pathologists
The College of American Pathologists is a not-for-profit medical society serving nearly 16,000 physician members and the laboratory community throughout the world. It is the world’s largest association composed exclusively of pathologists and is widely considered the leader in laboratory quality assurance. CAP is an advocate for high-quality and cost-effective patient care. More information about CAP can be found at http://www.cap.org.

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...